Drug intelligence / Profile preview

ExoWELL

Development stage: Preclinical
Lead developer: PranaX
Modality: Cell Therapies, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration: Not Explicitly Stated; Likely Intravenous Or Other Parenteral Routes Typical Of Exosome Therapies And Supplements.

Overview

ExoWELL is a physician-directed, GMP-compliant stem cell exosome supplement developed for application in health and wellness. It is designed to promote healthy aging, modulate cellular function, and support tissue regeneration. The product leverages exosome technology licensed from The University of Texas MD Anderson Cancer Center, which has been tested in clinical settings including Phase I safety studies. While primarily marketed as a wellness supplement for healthy individuals through clinics, the underlying technology is also being advanced for potential therapeutic use in age-related chronic diseases and regenerative medicine applications[8][10].

Brand names: ExoWELL
Other names: ExoWELL

Beyond the preview

Go deeper on ExoWELL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ExoWELL.

Explore the full profile